Modulation of Oncogenes with Preactivated Compounds
- 19 Downloads
In previous chapters we have described the antitumor and antiviral properties of novel compounds discovered via the application of the process of preactivation. The studies of the mechanism of action of these compounds have also been summarized. In this concluding chapter, data from ongoing studies related to the effect of preactivated merocyanine 540 (pMC540) on the modulation of selected oncogenes will be discussed.
KeywordsL1210 Cell L1210 Leukemia Cell
Unable to display preview. Download preview PDF.
- 2.Watt R, Wang A, Schein P. Altered c-myc gene expression in Burkitt lymphoma cells following nitrogen mustard treatment. Proc Am Assoc Cancer Res 1986; 27: 232.Google Scholar
- 9.Siebenblast U, Bressler P, Kelly K. Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL-60 cells. Mol Cell Biol 1988; 8: 867–74.Google Scholar
- 11.Reitsma P, Rothberg P, Astrin S et al. Rgulation of c-myc expression in HL-60 leukemic cells by a vitamin D metabolite. Nature 1983; 322: 848–50.Google Scholar
- 18.Watt R, Wang A, Schein P. Altered c-myc gene expression in Burkitt lymphoma cells following nitrogen mustard treatment. Proc Am Assoc Cancer Res 1986; 27: 232.Google Scholar
- 21.Chanh TC, Allan JS, Pervaiz S, Matthews JL, Gulliya KS. Preactivated merocyanine 540 inactivates HIV-1 and SIV: potential therapeutic and blood banking applications. J AIDS 1992; 5: 188–95.Google Scholar
- 22.Wiggs, R. B., Lobprise, H.B., Matthews, J.L. and Gulliya, K.S. Effects of preactivated MC540 in the treatment of lymphocytic plasmacytic stomatitis in feline leukemia virus and feline immunodeficiecy virus positive cats. J. Veterinary Dentistry, 1993; 10: 9–13.Google Scholar
- 24.Sharma RK Gulliya KS. Growth inhibitory effects of pMC540 and merodantoin on established MCF-7 human breast tumor xenografts. In Vivo 1995; 9: 103–108.Google Scholar
- 30.Futsher BW, Erickson LC. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents. Cancer Res 1990; 50: 62–66.Google Scholar
- 33.Osheroff N, Robinson MJ, Zechiedrich EL. Mechanism of the topoisimerase II-mediated DNA cleavage-religation reaction: Inhibition of DNA religation by antineoplastic drugs. In: Potmesil M Kohn KW, eds. DNA Topoisomerases in Cancer. Oxford University Press, 1991: 230–39.Google Scholar
- 36.Riou JF, Vilarem MJ, Larsen CJ et al. In vivo and in vitro stimulation by antitumor drugs of the topoisomerase II-induced cleavage sites of c-myc proto-oncogene. Natl Cancer Inst Monogr 1987; 4: 41–47.Google Scholar